Eton Park Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Eton Park Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,563,000	Closed	-$210M	–	38
2015 Q1	$210M	Hold	1,563,000	–	–	6.07%	5
2014 Q4	$196M	Buy	1,563,000 +444,000	+40%	+$54M	2.77%	12
2014 Q3	$136M	Buy	1,119,000 +687,000	+159%	+$83.5M	1.6%	22
2014 Q2	$51M	Buy	+432,000	New	+$50.8M	0.76%	38

Other funds holding TMO

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Eton Park Capital Management's TMO Position: Q2 2015 in Review

Eton Park Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2015, closing a stake of 1,563,000 shares — an estimated $210M sold.

Eton Park Capital Management first reported a position in TMO in Q2 2014 and held it in 4 quarters. The position peaked at $210M in Q1 2015. 974 funds tracked by Wall St. Rank hold TMO as of Q2 2015.

Eton Park Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2015 after selling out during the quarter.
Eton Park Capital Management sold 1,563,000 Thermo Fisher Scientific shares in Q2 2015, an estimated $210M.
Eton Park Capital Management first reported a position in Thermo Fisher Scientific in Q2 2014 and held it in 4 quarters.
Eton Park Capital Management's Thermo Fisher Scientific position peaked at $210M in Q1 2015.
974 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2015.

Based on Eton Park Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.